Literature DB >> 9176924

The functional significance of symptomatology and cognitive function in schizophrenia.

D I Velligan1, R K Mahurin, P L Diamond, B C Hazleton, S L Eckert, A L Miller.   

Abstract

The relationships between positive and negative symptomatology, cognitive function, and the ability to perform basic activities of daily living in patients with schizophrenia were examined in two studies. In study 1, 112 medicated patients were assessed utilizing the Brief Psychiatric Rating Scale (positive symptoms), the Negative Symptom Assessment (negative symptoms and cognitive function), and the Functional Needs Assessment (activities of daily living). Study 2 (n = 41), utilized the same measures of symptomatology and added a comprehensive neuropsychological test battery. Regression analyses in both studies determined that symptomatology predicts a relatively small amount of the variance in the ability to perform basic activities of daily living. Cognitive function, whether assessed with the Cognition subscale of the Negative Symptom Assessment or a comprehensive neuropsychological test battery, predicted over 40% of the variance in scores on the Functional Needs Assessment. A path model in which cognition predicted both concurrent symptomatology and activities of daily living and where symptomatology had little direct impact upon activities of daily living fit the data. The importance of addressing cognitive deficits in psychosocial intervention programs is discussed.

Entities:  

Mesh:

Year:  1997        PMID: 9176924     DOI: 10.1016/S0920-9964(97)00010-8

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  79 in total

Review 1.  Sources of heterogeneity in schizophrenia: the role of neuropsychological functioning.

Authors:  B E Seaton; G Goldstein; D N Allen
Journal:  Neuropsychol Rev       Date:  2001-03       Impact factor: 7.444

Review 2.  Very poor outcome schizophrenia: clinical and neuroimaging aspects.

Authors:  Serge A Mitelman; Monte S Buchsbaum
Journal:  Int Rev Psychiatry       Date:  2007-08

Review 3.  Real-world cognitive--and metacognitive--dysfunction in schizophrenia: a new approach for measuring (and remediating) more "right stuff".

Authors:  Danny Koren; Larry J Seidman; Morris Goldsmith; Phillip D Harvey
Journal:  Schizophr Bull       Date:  2006-01-05       Impact factor: 9.306

4.  Prediction of community outcome in schizophrenia 1 year after discharge from inpatient treatment.

Authors:  Andreas Wittorf; Georg Wiedemann; Gerhard Buchkremer; Stefan Klingberg
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-11-07       Impact factor: 5.270

Review 5.  Performance-based measures of functional skills: usefulness in clinical treatment studies.

Authors:  Philip D Harvey; Dawn I Velligan; Alan S Bellack
Journal:  Schizophr Bull       Date:  2007-05-09       Impact factor: 9.306

6.  A randomized controlled trial of cognitive remediation in schizophrenia.

Authors:  Marie Antoinette Redoblado Hodge; Daniella Siciliano; Pamela Withey; Beverley Moss; Genevieve Moore; Gaby Judd; E Arthur Shores; Anthony Harris
Journal:  Schizophr Bull       Date:  2008-08-20       Impact factor: 9.306

7.  Determinants of Employment Outcome for the People with Schizophrenia Using the WHODAS 2.0.

Authors:  Shu-Jen Lu; Tsan-Hon Liou; Chia-Feng Yen; Feng-Hang Chang; Yen-Ling Chen; Reuben Escorpizo; David R Strauser; Ay-Woan Pan
Journal:  J Occup Rehabil       Date:  2019-06

Review 8.  Neurocognitive mechanisms of conceptual processing in healthy adults and patients with schizophrenia.

Authors:  Tatiana Sitnikova; Christopher Perrone; Donald Goff; Gina R Kuperberg
Journal:  Int J Psychophysiol       Date:  2009-12-07       Impact factor: 2.997

9.  Cognitive effects of olanzapine and clozapine treatment in chronic schizophrenia.

Authors:  Tonmoy Sharma; Catherine Hughes; William Soni; Veena Kumari
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

10.  Predictors of community functioning in schizophrenia and substance use disorder patients.

Authors:  Simon Zhornitsky; Ginette Aubin; Joelle Desfossés; Elie Rizkallah; Tania Pampoulova; Olivier Lipp; Jean-Pierre Chiasson; Emmanuel Stip; Stéphane Potvin
Journal:  Community Ment Health J       Date:  2012-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.